Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells

Biochemical and Biophysical Research Communications

Volumn 415, Issue 2, 2011, Pages 245-251

  Chang, Charn Jung ^a   Chien, Yueh ^b,e   Lu, Kai Hsi ^b,e   Chang, Shih Ching ^c,e   Chou, Yueh Ching ^c,e,f   Huang, Chi Shuan ^b   Chang, Chin Hong ^d   Chen, Kuan Hsuan ^c,e   Chang, Yuh Lih ^a,c   Tseng, Ling Ming ^c,e   Song, Wen Shin ^b   Wang, Jhi Joung ^d   Lin, Jen Kou ^c,e   Huang, Pin I ^c,e   Lan, Yuan Tzu ^c,e  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Interleukin 32; Interleukin 8; Oct 4; Stemness

Indexed keywords

FLUOROURACIL; INTERLEUKIN 32; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; BIOINFORMATICS; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; DRUG RESISTANCE, NEOPLASM; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; INTERLEUKINS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3;

EID: 84855884797     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.10.024     Document Type: Article

References (34)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Cunningham D., Atkin W., Lenz H.J., Lynch H.T., Minsky B., Nordlinger B., Starling N. Colorectal cancer. Lancet 2010, 375:1030-1047.
3. Ricci-Vitiani L., Fabrizi E., Palio E., De Maria R. Colon cancer stem cells. J. Mol. Med. 2009, 87:1097-1104.
4. Todaro M., Francipane M.G., Medema J.P., Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010, 138:2151-2162.
5. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
6. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
7. Du L., Wang H., He L., Zhang J., Ni B., Wang X., Jin H., Cahuzac N., Mehrpour M., Lu Y., Chen Q. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008, 14:6751-6760.
8. Mizrak D., Brittan M., Alison M.R. CD133: molecule of the moment. J. Pathol. 2008, 214:3-9.
9. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
10. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., Hung S.C., Chang Y.L., Tsai M.L., Lee Y.Y., Ku H.H., Chiou S.H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 2008, 3:e2637.
11. Chiou S.H., Wang M.L., Chou Y.T., Chen C.J., Hong C.F., Hsieh W.J., Chang H.T., Chen Y.S., Lin T.W., Hsu H.S., Wu C.W. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010, 70:10433-10444.
12. Saigusa S., Tanaka K., Toiyama Y., Yokoe T., Okugawa Y., Ioue Y., Miki C., Kusunoki M. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann. Surg. Oncol. 2009, 16:3488-3498.
13. Todaro M., Perez Alea M., Scopelliti A., Medema J.P., Stassi G. IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 2008, 7:309-313.
14. Francipane M.G., Alea M.P., Lombardo Y., Todaro M., Medema J.P., Stassi G. Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res. 2008, 68:4022-4025.
15. Hwang W.L., Yang M.H., Tsai M.L., Lan H.Y., Su S.H., Chang S.C., Teng H.W., Yang S.H., Lan Y.T., Chiou S.H., Wang H.W. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011, 141:279-291. e275.
16. Sorrentino C., Di Carlo E. Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am. J. Respir. Crit. Care Med. 2009, 180:769-779.
17. Scheel C., Eaton E.N., Li S.H., Chaffer C.L., Reinhardt F., Kah K.J., Bell G., Guo W., Rubin J., Richardson A.L., Weinberg R.A. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell States in the breast. Cell 2011, 145:926-940.
18. Wang X.Q., Ongkeko W.M., Chen L., Yang Z.F., Lu P., Chen K.K., Lopez J.P., Poon R.T., Fan S.T. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 2010, 52:528-539.
19. Liu S., Ginestier C., Ou S.J., Clouthier S.G., Patel S.H., Monville F., Korkaya H., Heath A., Dutcher J., Kleer C.G., Jung Y., Dontu G., Taichman R., Wicha M.S. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 2011, 71:614-624.
20. Tsai K.S., Yang S.H., Lei Y.P., Tsai C.C., Chen H.W., Hsu C.Y., Chen L.L., Wang H.W., Miller S.A., Chiou S.H., Hung M.C., Hung S.C. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 2011.
21. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
22. Grivennikov S.I., Karin M. Inflammation and oncogenesis: a vicious connection. Curr. Opin. Genet. Dev. 2010, 20:65-71.
23. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117:1175-1183.
24. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14:6735-6741.
25. Rubie C., Frick V.O., Pfeil S., Wagner M., Kollmar O., Kopp B., Graber S., Rau B.M., Schilling M.K. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J. Gastroenterol. 2007, 13:4996-5002.
26. Cacev T., Radosevic S., Krizanac S., Kapitanovic S. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 2008, 29:1572-1580.
27. Itoh Y., Joh T., Tanida S., Sasaki M., Kataoka H., Itoh K., Oshima T., Ogasawara N., Togawa S., Wada T., Kubota H., Mori Y., Ohara H., Nomura T., Higashiyama S., Itoh M. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 2005, 29:275-282.
28. Bates R.C., DeLeo M.J., Mercurio A.M. The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Exp. Cell Res. 2004, 299:315-324.
29. Dahl C.A., Schall R.P., He H.L., Cairns J.S. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992, 148:597-603.
30. Kim S.H., Han S.Y., Azam T., Yoon D.Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
31. Netea M.G., Ferwerda G., de Jong D.J., Jansen T., Jacobs L., Kramer M., Naber T.H., Drenth J.P., Girardin S.E., Kullberg B.J., Adema G.J., Van der Meer J.W. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 2005, 174:6518-6523.
32. Marcondes A.M., Mhyre A.J., Stirewalt D.L., Kim S.H., Dinarello C.A., Deeg H.J. Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2865-2870.
33. Goda C., Kanaji T., Kanaji S., Tanaka G., Arima K., Ohno S., Izuhara K. Involvement of IL-32 in activation-induced cell death in T cells. Int. Immunol. 2006, 18:233-240.
34. Ning Y., Manegold P.C., Hong Y.K., Zhang W., Pohl A., Lurje G., Winder T., Yang D., LaBonte M.J., Wilson P.M., Ladner R.D., Lenz H.J. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128:2038-2049.